Searching over 5,500,000 cases.


searching
Buy This Entire Record For $7.95

Download the entire decision to receive the complete text, official citation,
docket number, dissents and concurrences, and footnotes for this case.

Learn more about what you receive with purchase of this case.

In Re: Pradaxa (Dabigatran Etexilate) Products

January 2, 2013

IN RE: PRADAXA (DABIGATRAN ETEXILATE) PRODUCTS LIABILITY LITIGATION


The opinion of the court was delivered by: David R. Herndon Chief Judge United States District Court

This Document Relates to:

THELMA BUTNER, CLIFTON FITZSIMMONS, JOHN WILCHINSKI, GEORGE FLETCHER, and PAULINE Case No. 3:12-cv-60092-DRH-SCW ALDRIDGE, Plaintiffs, v. BOEHRINGER INGELHEIM PHARMACEUTICALS, INC., et al., Defendants.

ORDER SETTING BRIEFING SCHEDULE FOR PENDING MOTIONS AND RESPONSIVE PLEADINGS

The Court hereby issues the following Order relating to the above-referenced action, which was transferred to MDL 2385 by the Judicial Panel on Multidistrict Litigation on December 7, 2012.

Pending Motions:

x Response by Boehringer Ingelheim Pharmaceuticals, Inc. ("BIPI") to Plaintiffs' Motion to Remand to be filed by January 2, 2013. Plaintiffs' Reply, if any, to be filed by January 16, 2013.

Further Responsive Pleadings:

x Deadlines to respond to all other pleadings in this action are stayed pending a ruling on the Plaintiff's Motion to Remand.

So Ordered:

Digitally signed by

Date: 2013.01.02 11:10:13 -06'00'

20130102

© 1992-2013 VersusLaw ...

Buy This Entire Record For $7.95

Download the entire decision to receive the complete text, official citation,
docket number, dissents and concurrences, and footnotes for this case.

Learn more about what you receive with purchase of this case.